Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
Showing 1810 results
September 2016
-
Story Discovery
A cellular drama at the heart of a researcher’s family
Jennifer Allport-Anderson hunts for cardiac cures.
-
Media Release
Alcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experience
Heads-up design using high definition 3D screen engineered to improve surgeons posture and may reduce fatigue[1] Offers enhanced 3D visualization with high-definition resolution, image… -
Media Release
Novartis' Ultibro® Breezhaler® consistently more effective than Seretide®* in reducing COPD flare-ups across different patient groups
Ultibro® Breezhaler® reduced rate of all COPD exacerbations across different patient sub-groups vs Seretide® in new analyses from FLAME study Analyses show that Ultibro Breezhaler lowered… -
Story Patient Perspectives
Giving a small community a big voice
Read a patient’s perspective on living with a rare, life-threatening blood cancer called myelofibrosis and why it’s important to rally the community.
August 2016
-
Media Release
AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment
New study shows that rate of patient persistence using Sandoz AirFluSal Forspiro is twice as high as for reference product Seretide® Diskus®. Study highlights importance of improving… -
Media Release
FDA approves Sandoz Erelzi(TM) to treat multiple inflammatory diseases
Erelzi is the first biosimilar etanercept approved by the FDA, offering expanded access to this important medicine Erelzi is approved for all indications included in the reference product's… -
Media Release
Novartis convenes experts to discuss new technologies in healthcare at Novartis International BioCamp
13th International Biotechnology Leadership Camp focuses on potential of new technologies to fundamentally transform biomedical research and the pharmaceutical business Interactive program… -
Media Release
Experten diskutieren am Novartis International BioCamp neue Technologien im Gesundheitsbereich
Im Zentrum des 13. International Biotechnology Leadership Camp steht das Potenzial neuer Technologien, die biomedizinische Forschung und die Pharmabranche grundlegend zu verändern Das interaktive… -
Media Release
Novartis convie plusieurs experts au Novartis International BioCamp afin de discuter des nouvelles technologies en matière de santé
La 13e édition de l'International Biotechnology Leadership Camp explore les nouvelles technologies susceptibles de révolutionner la recherche biomédicale et l'industrie pharmaceutique. Un programme… -
Featured News
Nurturing the next generation of scientists
Novartis internships help build research capabilities in developing countries.
-
Featured News
Students take on the challenges of digital medicine
Novartis BioCamp gives students new perspectives on healthcare challenges.
-
Story Discovery
In search of the differences that make the difference
Ambitious scientist accelerates research into African genomic diversity and health challenges with internship